Home › Actelion Rises After Winning Approval of Opsumit Lung Medicine
 

Keywords :   


Actelion Rises After Winning Approval of Opsumit Lung Medicine

2013-10-21 11:15:34| Biotech - Topix.net

Actelion Ltd. rose the most in more than 17 months after winning U.S. approval for the lung drug Opsumit, giving the Swiss company a successor to a best-selling medicine that loses patent protection in late 2015.

Tags: medicine approval winning lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
27.06CCA secures funding for wolf compensation in revised budget
27.06MU Extension to host 3 feedlot educational events this summer
27.06Whats your marketing plan for beef-on-dairy calves?
27.06Sunn hemp can boost summer pastures
27.06Supreme Court blocks $6bn Purdue bankruptcy deal
27.06Nippon Paint Marines FASTAR Coating Honored by JCIA
27.06Jeremy Sukola Named VP of Prime Resins
27.06Avery Dennison earns ARC performance certification for M800 inlay design
More »